Wedge Capital Management L L P Amneal Pharmaceuticals, Inc. Transaction History

Wedge Capital Management L L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	BUY	$3.01 - $4.46 $3,539 - $5,244	1,176 Added 3.92%	31,203 $99,000
Q1 2022 Apr 12, 2022	BUY	$3.9 - $4.89 $834 - $1,046	214 Added 0.72%	30,027 $125,000
Q4 2021 Jan 24, 2022	BUY	$3.95 - $5.85 $26,713 - $39,563	6,763 Added 29.34%	29,813 $143,000
Q3 2021 Oct 14, 2021	BUY	$4.31 - $5.64 $19,170 - $25,086	4,448 Added 23.91%	23,050 $123,000
Q2 2021 Jul 14, 2021	BUY	$5.12 - $6.82 $95,242 - $126,865	18,602 New	18,602 $95,000

184

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.18B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

Stay updated on Wedge Capital Management L L P with notifications on news.